Intermittent Fasting Inhibits High-Fat Diet–Induced Atherosclerosis by Ameliorating Hypercholesterolemia and Reducing Monocyte Chemoattraction

Atherosclerosis is a major pathology for cardiovascular diseases (CVDs). Clinically, the intermittent fasting (IF) has been observed to reduce the risk of CVDs. However, the effect of IF on the development of atherosclerosis has not been fully elucidated. Herein, we determined the protection of IF a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yuanli, Su, Jiamin, Yan, Yali, Zhao, Qian, Ma, Jialing, Zhu, Mengmeng, He, Xiaoyu, Zhang, Baotong, Xu, Hongmei, Yang, Xiaoxiao, Duan, Yajun, Han, Jihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517704/
https://www.ncbi.nlm.nih.gov/pubmed/34658858
http://dx.doi.org/10.3389/fphar.2021.719750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517704/
https://www.ncbi.nlm.nih.gov/pubmed/34658858
http://dx.doi.org/10.3389/fphar.2021.719750

Ejemplares similares